RAC 0.69% $1.46 race oncology ltd

Ann: Race Develops Improved IV Formulation of Zantrene, page-16

  1. 2,503 Posts.
    lightbulb Created with Sketch. 2646
    great insight, wasn’t aware of home infusion this is very interesting. Oral formulation is in the works so should provide holistic patient options.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.46
Change
0.010(0.69%)
Mkt cap ! $245.4M
Open High Low Value Volume
$1.47 $1.51 $1.43 $122.3K 82.91K

Buyers (Bids)

No. Vol. Price($)
1 69 $1.44
 

Sellers (Offers)

Price($) Vol. No.
$1.46 9999 1
View Market Depth
Last trade - 16.10pm 27/05/2024 (20 minute delay) ?
Last
$1.44
  Change
0.010 ( 1.71 %)
Open High Low Volume
$1.49 $1.50 $1.43 16871
Last updated 15.58pm 27/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.